MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Incidental iron deposition in basal ganglia: does the pattern matter? Fifteen years’ experience in a tertiary care center.

    á. Beltrán Corbellini, P. Pérez Torre, A. Alonso Cánovas, F. Rodríguez Jorge, JL. Chico García, P. Parra Díaz, E. Natera Villalba, A. Gómez López, S. Fanjul Arbos, JL. López Sendón, JC. Martínez Castrillo, I. Parées Moreno (Madrid, Spain)

    Objective: We describe our series of patients with iron deposition in basal ganglia (IDBG) and hypothesize differences regarding the affected nuclei in patients with movement…
  • 2019 International Congress

    Caudal posterior substantia nigra iron increases longitudinally in Parkinson’s disease

    N. Bergsland, R. Zivadinov, F. Schweser, J. Hagemeier, D. Lichter, T. Guttuso, JR. (Buffalo, NY, USA)

    Objective: To investigate spatial patterns and temporal evolution of substantia nigra (SN) iron accumulation in Parkinson’s disease (PD) using quantitative susceptibility mapping (QSM), an indirect…
  • 2019 International Congress

    Gray Matter Abnormalities in Parkinson’s disease: a Voxel-wise meta-analysis

    XR. Xu, Q. Han, JY. Lin, L. Wang, HF. Shang (Chengdu, China)

    Objective: To summarize the consistent GM volume changes in PD patients from whole brain VBM studies. Background: Grey matter (GM) anomaly in Parkinson’s disease (PD)…
  • 2019 International Congress

    Quantitative Susceptibility Mapping: an Biomarker for Diagnosis of Parkinson’s Disease and Evaluation Patients’ Condition

    LX. Xue, EH. Xu, JK. Li, Q. Yang, P. Chan (Beijing, China)

    Objective: To study deep gray matter susceptibility in Parkinson's Disease (PD) by using quantitative susceptibility mapping (QSM) and to assess the relationship between susceptibility value…
  • 2019 International Congress

    Identifying altered resting state network connectivity in Parkinson’s disease with mild cognitive impairment

    J. Yang, K. Mcmahon, D. Copland, G. Byrne, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

    Objective: To investigate brain connectivity associated with Parkinson's disease patient with mild cognitive impairment during resting-state fMRI Background: Cognitive disturbances in Parkinson’s disease (PD) is one…
  • 2019 International Congress

    Gray matter substrates of depression in blepharospasm

    J. Yang, YB. Hou, QQ. Wei, RW. Ou, W. Song, B. Cao, HF. Shang (Chengdu, China)

    Objective: This study aimed to investigate the cortical and subcortical gray matter (GM) volume substrates of depressive symptom in patients with BSP. Background: Primary blepharospasm…
  • 2019 International Congress

    Patterns of brain activity linked to Mild Behavioral Impairment in Parkinson’s disease

    EJ. Yoon, Z. Ismail, M. Kibreab, T. Hammer, J. Cheetham, I. Kathol, M. Ramezani, S. Lang, J. Sarna, D. Martino, S. Furtado, O. Monchi (Calgary, AB, Canada)

    Objective: To evaluate the association between Mild Behavioral Impairment (MBI) and pattern of brain activity during a set-shifting task in Parkinson’s disease (PD). Background: MBI…
  • 2019 International Congress

    Multimodal PET and fcMRI reveals regional modulation by STN DBS correlating to motor outcomes

    J. Younce, A. Tanenbaum, M. Campbell, J. Perlmutter, S. Norris (St Louis, MO, USA)

    Objective: To define brain networks modulated by deep brain stimulation (DBS) of the subthalamic nucleus (STN) and correlate connectivity with motor outcomes. Background: STN DBS…
  • 2019 International Congress

    Structural changes in non-manifesting GBA mutation carriers and GBA mutation carriers with Parkinson’s disease

    T. Yousaf, M. Kershaw, V. Suarez Contreras, P. Vickers, G. Pagano, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate whether GBA mutations are associated with structural abnormalities in a cohort of GBA mutation carriers with and without manifested PD.…
  • 2019 International Congress

    Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

    T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)

    Objective: To compare single-photon emission computed tomography (SPECT) with [123I]FP-CIT and positron emission tomography (PET) with [11C]PE2I as markers of dopamine transporter (DAT) loss in…
  • « Previous Page
  • 1
  • …
  • 1364
  • 1365
  • 1366
  • 1367
  • 1368
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley